,

COST-EFFECTIVENESS ANALYSIS OF PALIVIZUMAB WITH RISK FACTORS FOR RESPIRATORY SYNCYTIAL VIRUS PREVENTION

,

Future Direction of Drug Safety Policy

,

Government Policy on Reimbursement and Pricing in S Korea

,

Innovative Pricing Model to Improve Patient access in Korea.

,

Lessons from Public-Private Partnership with Pharmaceutical Industry in Korea.